cytarabine has been researched along with vancomycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pizzo, PA; Walsh, TJ | 1 |
| Roda, PI | 1 |
| Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B | 1 |
| Adcock, KG; Akins, RL; Farrington, EA | 1 |
| Heisel, RW; Lim, SH; Mascara, GP; Oleksiuk, LM; Sutton, RR; Weber, DR; Winger, DG | 1 |
| Hoover, A; Modi, A; Wiese, S; Zimmerman, JAO | 1 |
1 review(s) available for cytarabine and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for cytarabine and vancomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.
Topics: Animals; Candida albicans; Candidiasis; Cytarabine; Disease Models, Animal; Female; Gastrointestinal Diseases; Gentamicins; Immunocompromised Host; Intestinal Mucosa; Methylprednisolone; Rabbits; Vancomycin | 1992 |
Clostridium difficile colitis induced by cytarabine.
Topics: Aged; Cytarabine; Enterocolitis, Pseudomembranous; Humans; Leukemia, Myeloid; Male; Vancomycin | 1987 |
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin | 1996 |
Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytarabine; Female; Fever; Humans; Infant; Male; Neutropenia; Retrospective Studies; Vancomycin | 1999 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabine; Dalteparin; Dapsone; Dermatitis, Contact; Drug Hypersensitivity; Felodipine; Female; Humans; Male; Middle Aged; Phenytoin; Pregnancy; Pyrazoles; Scabies; Sulfonamides; Sweet Syndrome; Vancomycin | 2002 |
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Cytarabine; Female; Gram-Positive Bacterial Infections; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bacteremia; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Female; Fever; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Prognosis; Retrospective Studies; Vancomycin; Young Adult | 2021 |